Avalo Therapeutics stock surges 35% on positive trial data
Investing.com Gold reports: Avalo Therapeutics stock surges 35% on positive trial data. Full body text was unavailable at ingest time, so this brief is based on headline context.
Investing.com Gold reports: Avalo Therapeutics stock surges 35% on positive trial data. Full body text was unavailable at ingest time, so this brief is based on headline context.